Delaware, U.S. – The automated suturing devices market is projected to observe significant expansion by 2027 owing to rising incidences of chronic diseases requiring surgical interventions globally.
Automation of suturing devices has increased the efficacy and precision of performing minimally invasive surgical procedures by reducing the possibility of human error. Automated suturing devices offer several benefits like high accuracy, increased speed, greater access to hard-to-reach areas, and fewer incidences of needle stick injuries among medical practitioners. Latest technological advances focusing on product enhancement have also driven market adoption in recent years.
Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/5120
Notably, prominent industry players are employing lucrative business strategies to tap into prevalent market trends, which has favorably altered market dynamics. For instance, in June 2021, Ethicon, a Johnson & Johnson medical devices company, launched an advanced bipolar energy device dubbed the ENSEAL X1 Curved Jaw Tissue Sealer.
The ENSEAL X1 Curved Jaw has been designed to improve surgical efficiency in multiple procedures viz., bariatric surgery, gynecological procedures, colorectal procedures, and thoracic procedures. It also offers various features, including separate cut and seal capabilities and a 360-degree shaft rotation that facilitates easy access to the target tissue.
The automated suturing devices market has been segmented based on application, product type, end-use, and region. Based on product type, the market has further been bifurcated into disposable and reusable.
The reusable sub-segment held over 33% share in the market in 2020 and is foreseen to witness steady growth through the analysis period. Low costs and easy availability of reusable automated suturing devices are set to bolster segmental demand in the coming years.
With respect to application, the market has been divided into open surgeries, minimally invasive surgeries, trauma cases, and others. The minimal invasive surgeries sub-segment garnered above 32% market share in 2020 and is expected to amass substantial gains by 2027 driven by the rising number of minimally invasive procedures undertaken. In addition, technological advancements in the sector are likely to boost segmental growth over the following years.
Request for Customization @ https://www.gminsights.com/roc/5120
In terms of end-use, the automated suturing devices market has been categorized into clinics, hospitals, ambulatory surgical centers, and others. The hospitals sub-segment is slated to progress at a CAGR of more than 5.9% over the forecast period on account of increasing number of surgeries performed in hospitals. Moreover, mounting presence of skilled staff in hospitals is set to fuel segmental adoption in the forthcoming years.
From the regional point of view, the North America automated suturing devices market exceeded a valuation of USD 200 million in 2020 and is anticipated to exhibit robust growth over 2021-2027. Surging awareness about minimally invasive procedures, escalating number of product launches, and high spending on advanced technology devices are estimated to propel regional market expansion in the future.